O nimodipino é um bloqueador de canais de cálcio usado principalmente na terapia da hemorragia subaracnóidea e no tratamento de distúrbios cognitivos. É praticamente insolúvel em água e, pelo Sistema de Classificação Biofarmacêutica (SCB), é qualificado como classe II e, portanto, sua dissolução é etapa limitante da absorção, podendo apresentar problemas de biodisponibilidade. Assim, o objetivo do trabalho foi desenvolver e caracterizar dispersões sólidas de nimodipino, obtidas com os carreadores PEG 6000 ou Poloxamer 407 e compará-las quanto à melhoria na solubilidade e na dissolução do nimodipino. As dispersões sólidas foram obtidas pelos métodos de fusão e de evaporação do solvente e foram caracterizadas pelas técnicas de calorimetria exploratória diferencial (DSC), espectroscopia de absorção na região do infravermelho (FT-IR) e difração de raios-X, cujos resultados comprovaram a obtenção das dispersões sólidas. As características de solubilidade e de dissolução do nimodipino nas dispersões sólidas e em misturas físicas foram comparadas. As dispersões sólidas contendo poloxamer 407 apresentaram maior eficiência em melhorar a solubilidade e a velocidade de dissolução do nimodipino, o que pode ser explicado pelo seu efeito tensoativo. O aumento da solubilidade das dispersões sólidas preparadas com PEG (DSPEG-10 = 13,2 g.mL-1) foi significativamente maior que aquele devido às misturas físicas de mesma composição (MFPEG-10 = 3,21 g.mL-1) que, por sua vez, apresentaram solubilidade maior que a do fármaco (2,19 g.mL-1). O mesmo ocorreu com a eficiência de dissolução dessas preparações (DSPEG-10 = 69,11% , MFPEG-10 = 15,61% e nimodipino = 11,68%). Maior incremento da solubilidade foi obtido com a dispersão sólida produzida pelo método de evaporação do solvente contendo poloxamer 407 como carreador (SOLVP407-10 = 75,61 g.mL-1). / Nimodipine is a calcium blocker, used in prevention and treatment of ischaemic neurological deficits after aneurismal subarachnoid hemorrhage and cognitive deficit. It exhibits a low solubility in water and it is classified as class two in the Biopharmaceutics Classification System (BCS), thereby dissolution is the ratelimiting step in absorption, which impact on bioavailability. Consequently, the objective of this study was to develop and characterize solid dispersions of nimodipine, prepared with PEG 6000 or Poloxamer 407 and to compare them in terms of nimodipine solubility and dissolution. Solid dispersions were obtained by fusion and solvent methods and they were characterized by differential scanning calorimetry (DSC), infra red spectroscopy (FT-IR) and X-ray diffraction, where results confirmed the formation of solid dispersions. Solubility and dissolution characteristics of nimodipine in solid dispersions and physical mixtures were compared. Solid dispersions containing poloxamer 407 showed better efficiency than PEG in increasing solubility and dissolution rate of nimodipine, and it can be explained due to its surfactant activity. The solubility results obtained with solid dispersions prepared with PEG 6000 (DSPEG-10 = 13,2 g.mL-1) were better than physical mixtures with the same composition (MFPEG-10 = 3,21 g.mL-1) which, in turn, showed increased solubility compared with nimodipine (2,19 g.mL-1). Similar results were observed for dissolution efficiency (DSPEG-10 = 69,11% , MFPEG-10 = 15,61% and nimodipine = 11,68%). The best solubility result was obtained by the formulation prepared by the solvent method with poloxamer 407 as carrier (SOLVP407-10 = 75,61 g.mL-1).

L'Imagerie par Résonance Magnétique (IRM) est une technique d'imagerie médicale largement répandue dans les milieux hospitaliers pour le diagnostic de pathologies. Elle repose classiquement sur la détection du proton (IRM 1H) et permet de visualiser des tissus en profondeur avec une très bonne résolution temporelle et spatiale. Cependant, cette méthode souffre encore de sa faible sensibilité. Une des solutions consiste en l'introduction et la détection de xénon hyperpolarisé. En effet, le xénon est un gaz non toxique, très sensible à son environnement chimique et adapté pour l’IRM. Cependant, il n'est spécifique d'aucun récepteur biologique et nécessite des molécules particulièrement adaptées pour son encapsulation. La détection de cibles spécifiques se fait par des biosondes constituées de molécules cages fonctionnalisées par une antenne de reconnaissance d'un récepteur spécifique. Le xénon vient s'encapsuler dans cette molécule hôte et permet la localisation de la cible biologique. Parmi les molécules cages répertoriées dans la littérature, les cryptophanes présentent la plus forte affinité connue pour le xénon et sont donc les plus prometteuses. Les cryptophanes sont des molécules cages constituées de deux unités de type cyclotribenzylène reliées entre elles par trois chaînes pontantes. Ils ont été synthétisés pour la première fois par l'équipe d'A. Collet au Collège de France au début des années 1980. L'objectif de cette thèse a été de synthétiser et de fonctionnaliser de nouveaux cryptophanes. / Non-invasive proton magnetic resonance imaging (1H MRI) is a powerful clinical tool for the detection of numerous diseases. Although MRI contrast agents are often used to improve diagnostic specificity, this technique has limited applications in molecular imaging because of its inherently low sensitivity when compared to nuclear medicine or fluorescence imaging. Laser-polarized 129Xe NMR spectroscopy is a promising tool to circumvent sensitivity limitations. Indeed, optical pumping increases the nuclear spin polarization of xenon by several orders of magnitude (104 to 105), thus small amounts of gas dissolved in biological tissues (blood, lungs…) can be rapidly detected with an excellent signal-to-noise ratio. In addition, the high polarizability of the xenon electron cloud, which induces a very high sensitivity to its environment, makes this nucleus very attractive for molecular imaging. Detection of biomolecules can be achieved by biosensors, which encapsulate xenon atoms in molecular cages that have been functionalized to bind the desired biological target. Cage molecules such as cryptophanes have high affinity for xenon and thus appear as ideal candidates for its encapsulation. During this PhD thesis we worked on the synthesis and the functionalization of new cryptophanes.

O nimodipino é um bloqueador de canais de cálcio usado principalmente na terapia da hemorragia subaracnóidea e no tratamento de distúrbios cognitivos. É praticamente insolúvel em água e, pelo Sistema de Classificação Biofarmacêutica (SCB), é qualificado como classe II e, portanto, sua dissolução é etapa limitante da absorção, podendo apresentar problemas de biodisponibilidade. Assim, o objetivo do trabalho foi desenvolver e caracterizar dispersões sólidas de nimodipino, obtidas com os carreadores PEG 6000 ou Poloxamer 407 e compará-las quanto à melhoria na solubilidade e na dissolução do nimodipino. As dispersões sólidas foram obtidas pelos métodos de fusão e de evaporação do solvente e foram caracterizadas pelas técnicas de calorimetria exploratória diferencial (DSC), espectroscopia de absorção na região do infravermelho (FT-IR) e difração de raios-X, cujos resultados comprovaram a obtenção das dispersões sólidas. As características de solubilidade e de dissolução do nimodipino nas dispersões sólidas e em misturas físicas foram comparadas. As dispersões sólidas contendo poloxamer 407 apresentaram maior eficiência em melhorar a solubilidade e a velocidade de dissolução do nimodipino, o que pode ser explicado pelo seu efeito tensoativo. O aumento da solubilidade das dispersões sólidas preparadas com PEG (DSPEG-10 = 13,2 g.mL-1) foi significativamente maior que aquele devido às misturas físicas de mesma composição (MFPEG-10 = 3,21 g.mL-1) que, por sua vez, apresentaram solubilidade maior que a do fármaco (2,19 g.mL-1). O mesmo ocorreu com a eficiência de dissolução dessas preparações (DSPEG-10 = 69,11% , MFPEG-10 = 15,61% e nimodipino = 11,68%). Maior incremento da solubilidade foi obtido com a dispersão sólida produzida pelo método de evaporação do solvente contendo poloxamer 407 como carreador (SOLVP407-10 = 75,61 g.mL-1). / Nimodipine is a calcium blocker, used in prevention and treatment of ischaemic neurological deficits after aneurismal subarachnoid hemorrhage and cognitive deficit. It exhibits a low solubility in water and it is classified as class two in the Biopharmaceutics Classification System (BCS), thereby dissolution is the ratelimiting step in absorption, which impact on bioavailability. Consequently, the objective of this study was to develop and characterize solid dispersions of nimodipine, prepared with PEG 6000 or Poloxamer 407 and to compare them in terms of nimodipine solubility and dissolution. Solid dispersions were obtained by fusion and solvent methods and they were characterized by differential scanning calorimetry (DSC), infra red spectroscopy (FT-IR) and X-ray diffraction, where results confirmed the formation of solid dispersions. Solubility and dissolution characteristics of nimodipine in solid dispersions and physical mixtures were compared. Solid dispersions containing poloxamer 407 showed better efficiency than PEG in increasing solubility and dissolution rate of nimodipine, and it can be explained due to its surfactant activity. The solubility results obtained with solid dispersions prepared with PEG 6000 (DSPEG-10 = 13,2 g.mL-1) were better than physical mixtures with the same composition (MFPEG-10 = 3,21 g.mL-1) which, in turn, showed increased solubility compared with nimodipine (2,19 g.mL-1). Similar results were observed for dissolution efficiency (DSPEG-10 = 69,11% , MFPEG-10 = 15,61% and nimodipine = 11,68%). The best solubility result was obtained by the formulation prepared by the solvent method with poloxamer 407 as carrier (SOLVP407-10 = 75,61 g.mL-1).

INTRODUÇÃO: O nervo facial (NF) desempenha um papel importante em diversas funções fisiológicas do organismo e controla a musculatura da mímica facial, responsável por transmitir sentimentos e emoções. O tratamento padrão-ouro para reconstrução do NF após trauma com secção é a anastomose término-terminal com cola de fibrina, que na maioria dos casos ainda produz resultados subótimos. Por isso, objetivou-se testar o efeito de uma nova técnica de reconstrução usando um protocolo de fusão axonal por polietilenoglicol (PEG), denominada sutura química, utilizando parâmetros eletrofisiológicos e histomorfométricos. MÉTODOS: Ratos Wistar foram divididos em 4 grupos. Após transecção do ramo mandibular do NF, o grupo controle foi submetido a anastomose dos cotos neurais com microssuturas. O grupo 2 foi tratado com microssuturas mais a sutura química. A sutura química consistiu de lavagem dos cotos neurais com solução de Krebs hipotônica contendo azul de metileno antes das microssuturas. Depois da sutura, seguiu-se a lavagem com solução de PEG e, por último, aplicação de solução de Krebs contendo cálcio. O grupo 3 recebeu microssuturas mais a solução com azul de metileno. E o grupo 4 foi tratado com microssuturas mais a solução de PEG. Os potenciais de ação musculares compostos (PAMCs) foram avaliados no pré-operatório e após 3 e 6 semanas das intervenções. A análise histomorfométrica foi realizada após 6 semanas. RESULTADOS: Os animais submetidos à sutura química apresentaram maior amplitude e menor duração dos PAMCs 3 e 6 semanas após a cirurgia em comparação com todos os demais grupos; na análise histológica, apresentaram maior contagem axonal e maior diâmetro axonal. CONCLUSÕES: A sutura química produziu recuperação mais intensa do NF após secção e sutura quando comparada à sutura isoladamente, pela avaliação eletrofisiológica e histomorfométrica, e pode ser útil em situações clinicas nas quais haja secção seguida de reparo neural imediato / BACKROUND: The gold standard treatment for traumatic transection of the FN continues to be end-to-end anastomosis using fibrin glue, which often yields unsatisfying results. OBJECTIVE: To test the outcome of a novel method of polyethylene glycol (PEG)-fusion on FN transection using electrophysiological and histophormometric parameters. METHODS: Wistar rats were divided into 4 groups. After FN transection, the control group was submitted to end-to-end anastomosis with microsutures. Group 2 was submitted to microsutures plus the PEG-fusion protocol. This protocol consisted in bathing nerve stumps with a calcium-free Krebs solution containing methylene blue (MB) before suturing. After suturing, the repaired nerve received a PEG solution followed by a calcium-containing Krebs solution. Group 3 received microsutures plus the MB solution and group 4 received microsutures plus the PEG solution. Compound muscle action potentials (CMAPs) were recorded before the intervention and 3 and 6 weeks afterwards. Histomorphometric analysis was done at 6 weeks time. RESULTS: The PEG-fusion protocol yielded larger CMAP amplitude, smaller CMAP duration at 3 and 6 weeks and a larger axon count and axon diameter. Between the other groups, no significant difference was seen. CONCLUSION: PEG-fusion produces better FN recovery after transection, when considering electrophysiological and histomorphometric analysis and may be of use in clinical scenarios of FN cut-severance followed by immediate repair

A cerebral aneurysm is a weakened area of an artery in the brain, creating an abnormal expansion. Recent research for treatment is utilizing a photopolymerizable hydrogel as a possible operation for injection in situ. This paper aimed to achieve bioconjugation of peptides on a PEGDMA polymer network (using the photoinitiator PEG-BAPO) to form a biocompatible photopolymerizable hydrogel, without compromise to any of its mechanical attributes. Achieving cell adhesion to the hydrogel surface is a critical requirement as that could drive the growth of endothelium between aneurysm and artery, to considerably enhance its sustainability and decrease the risk of inflammation. The hydrogel was synthesized by functionalizing RGD with a PEG-spacer and co-polymerize it with PEGDMA using UV-radiation to create an intertwined cross-linking network. Samples of various peptide concentrations were studied in cell culture to analyze cell adhesion, followed by mechanical tests to identify possible deviations. A subsequent study was established to create a dynamic prototype as a quantifiable replication of a hydrogel inside an aneurysm in vivo. The model was designed in SolidWorks and connected with an Ibidi sticky-Slide to roughly replicate a cerebral aneurysm connected to an artery with space to introduce a hydrogel sample.

The aortic valve maintains unidirectional blood flow between the left ventricle and the systemic circulation. When diseased, the valve is replaced either by a mechanical or a bioprosthetic heart valve, that carry issues such as thrombogenesis, long term structural failure, and calcification, necessitating the development of more structurally and biologically sufficient long-term replacements. Tissue engineering provides a possible avenue for development, combining cells, scaffolds, and biochemical factors to regenerate tissue. The overall goal of this dissertation was to create a foundation for the rational design of a tissue engineered aortic valve. The novel approach taken in this thesis research was to view each of the three leaflets as a laminate structure. The first three aims consider the leaflet as a laminate structure comprising of layers of collagen, elastin, and glycosaminoglycans (GAGs). In the first aim, the effect of GAGs on the tensile properties and stress relaxation in the leaflet was investigated, by removing GAGs through increasing amounts of hyaluronidase. A decrease in GAGs led to significantly higher elastic moduli, maximum stresses, and hysteresis in the leaflet. In the second aim, the 3D elastic fiber network of the leaflet was characterized using immunohistochemistry and scanning electron microscopy. This structure was found to have regionally varying thicknesses and patterns. In the third aim, a novel hydrogel-fiber composite design was proposed to match the anisotropy of the leaflet. This composite composed of aligned electrospun poly(ε-caprolactone) (PCL) within a poly(ethylene glycol) diacrylate (PEGDA) matrix. Surface modification and embedding of the PCL did not significantly alter the anisotropy or strength of the underlying PCL scaffold, providing the basis for an anisotropic, biocompatible scaffold. In the last aim, a novel co-culture model was designed using magnetic levitation as a layered structure of valvular endothelial cells and interstitial cells. This technique was used to create co-culture models within hours, while maintaining cell phenotype and function, and inducing extracellular matrix formation, as shown by immunohistochemical stains and their gene expression profiling. The overall result of this dissertation is a clearer understanding of the layered structure-function relationship of the aortic valve, and its application towards heart valve tissue engineering.

Cellulose nanofibrils (CNFs) are nanoscale fibers of high aspect ratio that can be isolated from a wide variety of cellulosic sources, including wood and bacterial cellulose. With high strength despite of their low density, CNFs are a promising renewable building block for the preparation of nanostructured materials and composites. To fabricate CNF-based materials with improved inherent rheological and mechanical properties and additional new functionalities, it is essential to tailor the surface properties of individual CNFs. The surface structures control the interactions between CNFs and ultimately dictate the structure and macroscale properties of the bulk material. In this thesis we have demonstrated different approaches, ranging from non-covalent adsorption and covalent chemical modification to modification of cellulose biosynthesis, to tailor the structure and surface functionalities of CNFs for the fabrication of advanced materials. These materials possess enhanced properties such as water-redispersibility, water absorbency, dye adsorption capacity, antibacterial activity, and mechanical properties. In Paper I, CNFs were modified via the irreversible adsorption of carboxymethyl cellulose (CMC). The adsorption of small amounts of CMC onto the surface of CNFs prevented agglomeration and co-crystallization of the nanofibrils upon drying, and allowed the recovery of rheological and mechanical properties after redispersion of dried CNF samples. In Paper II, CNFs bearing permanent cationic charges were prepared through quaternization of wood pulp fibers followed by mechanical disintegration. The activation of the hydroxyl groups on pulp fibers by alkaline treatment was optimized prior to quaternization. This optimization resulted in individual CNFs with uniform width and tunable cationic charge densities. These cationic CNFs demonstrated ultrahigh water absorbency and high adsorption capacity for anionic dyes. In Paper III, via a similar approach as in Paper II, CNFs bearing polyethylene glycol (PEG) were prepared by covalently grafting PEG to carboxylated pulp fibers prior to mechanical disintegration. CNFs with a high surface chain density of PEG and a uniform width were oriented to produce macroscopic ribbons simply by mechanical stretching of the CNF hydrogel network before drying. The uniform grafted thin monolayer of PEG on the surface of individual CNFs prevented the agglomeration of CNFs and facilitated their alignment upon mechanical stretching, thus resulted in ribbons with ultrahigh tensile strength and modulus. These optically transparent ribbons also demonstrated interesting biaxial light scattering behavior. In Paper IV, bacterial cellulose (BC) was modified by the addition of chitin nanocrystals (ChNCs) into the growing culture medium of the bacteria Acetobacter aceti which secretes cellulose in the form of entangled nanofibers. This led to the in situ incorporation of ChNCs into the BC nanofibers network and resulted in BC/ChNC nanocomposites exhibiting bactericidal activity. Further, blending of BC nanofibers with ChNCs produced nanocomposite films with relatively lower tensile strength and modulus compared to the in situ cultivated ones. The bactericidal activity increased significantly with increasing amount of ChNCs for nanocomposites prepared by direct mixing of BC nanofibers and ChNCs. In Paper V, CNFs were isolated from suspension-cultured wild-type (WT) and cellulose-binding module (CBM) transformed tobacco BY-2 (Nicotiana tabacum L. cv bright yellow) cells. Results from strong sulfuric acid hydrolysis indicated that CNFs from transgenic cells overexpressing CBM consisted of longer cellulose nanocrystals compared to CNFs from WT cells. Nanopapers prepared from CNFs of transgenic cells demonstrated significantly enhanced toughness compared to CNFs of WT cells. / <p>QC 20141103</p> / CARBOMAT

Environmentally benign alternatives for solvents and catalysts are essential for the development of sustainable chemical processes. Toward this end, we focused our research on the design of novel solvents and catalysts that reduce the environmental impact of these important materials. In this research, we develop switchable and tunable systems that couple reaction and separation to ease the processing requirements for product isolation and catalyst recovery. The switchable solvents use a ¡°switch¡± to transition from non-volatile, polar, aprotic solvents to volatile gases that can be easily separated. This allows us to facilitate reactions within the solvent and then enable easy separation through activation of the switch. We have used these materials for numerous reaction applications, including difficult reactions involving highly immiscible compounds. We also extended the work to acid-catalyzed reactions, in which we can avoid wasteful neutralization processes that are often associated with homogeneous acid catalysis. The tunable solvents use carbon dioxide pressure to ¡°tune¡± into desired solvent properties. We enable this through the dissolution of carbon dioxide into organic solvents, which generates gas-expanded liquids with solvent properties highly dependent on the carbon dioxide pressure. We can use this effect to couple homogeneous reaction with heterogeneous separation, allowing for recovery of expensive catalysts and ligands. In this work, we assess the possibilities of using liquid polyethylene glycol in the tunable systems, studying the phase behavior and industrial applications.

Quantum dots (QDs) are potentially advantageous tools for both diagnostics and therapeutics due to their light emitting characteristics. The impact of QDs on biological systems however, is not fully understood. The aim of this project therefore, was to investigate the interaction of a series of different surface modifies QDs with macrophages and their subsequent toxicity. CdTe/CdSe (core), ZnS (shell) QDs with either an organic, COOH or NH2 polyethylene glycol (PEG) surface coatings were used. Fluorescent COOH polystyrene beads (PBs) at (Ø) 20nm and 200nm were also studied. J774.A1 murine ‘macrophage-like' cells were treated for two hours with QDs (40nM) of PBs ($50μg.ml^{-1}$) in the presence of 10% FCS prior to assessment of cellular uptake via confocal microscopy and flow cytometry. COOH and $NH_{2}$ (PEG) QDs, as well as 20nm and 200nm PBs entered macrophages within 30 minutes, and were found to locate within endosomes, lysosomes and the mitochondria. T.E.M. also illustrated particles, including organic QDs, to be present inside J774.A1 cells within membrane- bound vesicles at two hours. Organic QDs were unable to be visualised via fixed cell confocal microscopy. Live cell confocal microscopy (without 10% FCS) did suggest however, that organic QDs entered cells in low quantities up to 30 minutes, after which fluorescence declined. Particle toxicity was determined over 48 hours via the MTT, LDH and GSH assays, as well as via assessment of their potential to produce the pro-inflammatory cytokine (TNF-α) and effect cytosolic $Ca^{2+}$ signalling in the J774.A1 cells. Organic QDs were found to be highly toxic at all time points and concentrations used. Both COOH and $NH_{2 }$ (PEG) QDs induced significant (p<0.0001) cytotoxicity (MTT and LDH assays) at 80nM after 48 hours, as well as significant (p<0.01) GSH depletion over 24 hours at all doses, as well as increasing the level of cytosolic $Ca^{2+}$ at 40nM when assessed over 30 minutes. Organic and NH2 (PEG) QDs were found to significantly increase TNF-α production after 24 hours at 80nM. The findings of this study demonstrate that QDs differ in their uptake by macrophages according to their surface coating, with the organic surface coated QDs being the most toxic. At sub-lethal concentrations, in the presence of 10% FCS, the COOH and $NH_{2}$ (PEG) QDs are taken up resulting in GSH depletion and modulated $Ca^{2+}$ signalling, with $NH_{2}$ (PEG) QDs and organic QDs only eliciting limited TNF-α production. Interestingly however, despite these observations, QD surface coating does not affect the intracellular fate of these NPs, with all of the different surface coated QDs observed to be present in endosomes, lysosomes and the mitochondria within J774.A1 macrophage cells. Therefore, in conclusion, the surface coating of QDs plays a significant role in their interaction with macrophages, their uptake and their subsequent toxicity.

A epilepsia é normalmente a associação de pré-disposição genética e doença ou uma lesão cerebral. Aproximadamente 1 entre 50 a 100 pessoas apresentam essa pré-disposição à convulsões. Um dos fármacos mais prescritos e utilizados para o tratamento de convulsões é o ácido valpróico (AV), tornando-se a medicação de primeira escolha no tratamento da epilepsia infantil por apresentar um amplo espectro de ação, embora apresente efeitos colaterais bastante conhecidos como pancreatite e a hepatotoxicidade, que pode ser fatal. Sistemas nanoparticulados como nanocápsulas, obtidas a partir da utilização de polímeros biodegradáveis como o polietilenoglicol (PEG) e macromoléculas naturais como a quitosana (QS), que proporcionam hidrofilia e bioadesividade, têm sido estudadas com o objetivo de aumentar a penetração cerebral e reduzir a dosagem do fármaco. Nesse contexto, o presente trabalho teve como objetivo desenvolver e caracterizar físico-quimicamente nanocápsulas de poli(ε-caprolactona) contendo AV e revestidas com QS (NCQ) e/ou com PEG 6000 (NCP e NCQP), investigar a farmacocinética plasmática, a penetração do AV através da barreira hematoencefálica (BHE) por microdiálise e a hepatotoxicidade em ratos Wistar. Nanocápsulas revestidas com QS (NCQ) foram obtidas pelo método de nanoprecipitação do polímero pré-formado seguido do revestimento com adição de 5 mL de solução de QS a 1%. Para a preparação de NCP, foi utilizada metodologia similar adicionando 0,7% de PEG 6000 na fase aquosa. Para a preparação de NCQP, as nanocápsulas preparadas com a adição de 0,35% de PEG 6000 e revestidas posteriormente com solução de QS a 1% (2,5 mL). As formulações foram caracterizadas físico-quimicamente avaliando-se o tamanho das partículas, potencial zeta, pH e taxa de incorporação. As nanocápsulas foram visualizadas por MET e a estabilidade foi investigada por retroespalhamento de luz (Turbiscan Lab®). As formulações (AV 5 mg/mL) apresentaram um pequeno tamanho de partícula (144,2 ± 2,0 nm, 153,2 ± 1,8 nm, e 231,3 ± 15,6 nm, para NCQ, NCP e NCQP, respectivamente), com baixo índice de polidispersão, alta taxa de incorporação (95 a 98 %), pH ácido, potencial zeta positivo para NCQ (+8,7 ± 0,4 mV) e negativo para NCP (- 6,6 ± 0,8 mV) e NCQP (- 2,8 ± 1,3 mV). As fotomicrografias mostraram partículas de forma esférica e as formulações demonstraram boa estabilidade durante 24h de análise a 40°C. As concentrações plasmáticas foram investigadas em ratos Wistar (15 mg/kg via i.v. de AV) para todas as formulações e valproato sódico (grupo controle). A análise farmacocinética compartimental apresentou uma distribuição muito rápida para o AV em NCQ e a ASC0-∞ aproximadamente duas vezes menor em comparação à NCP, NCQP e o fármaco livre (3874 ± 1775; 8280 ± 2136; 7849 ± 1021 e 7978 ± 3622 μg/mL/min, respectivamente). O clearance do AV aumentou significativamente para NCQ (0,284 ± 0,156 L/h/kg) (α = 0,05%). A penetração do AV através da BHE foi realizada em ratos Wistar acordados por microdiálise (MD) cerebral, no córtex frontal utilizando sondas CMA/12 (3 mm). Os experimentos de MD mostraram um aumento de 5 vezes no fator de penetração cerebral após a administração de NCQ em comparação com o fármaco em solução (0,110 and 0,021, respectivamente), demonstrando a viabilidade da utilização de QS como polímero de revestimento objetivando a BHE. A NCP demonstrou um aumento de 1,7 vezes no fator de penetração cerebral e NCQP não demonstrou qualquer diferença na penetração. A investigação da hepatotoxicidade do AV foi realizada após cinco dias de tratamento (dose de 30 mg/kg q12h de AV) em solução ou em nanocápsulas (NCQ ou NCP) com grupo controle de solução salina. Os níveis séricos de asparto aminotransferase (AST), alanina aminotransferase (ALT), gama-glutamiltransferase (GGT), fosfatase alcalina (FAL), creatinina (CRE) e uréia foram determinados. Os resultados mostram a manutenção dos níveis normais de enzimas hepáticas como a ALT e FAL para NCQ (54,2 ± 11,2 UI/mL and 149 ± 26 UI/mL) demonstrando um efeito hepatoprotetor não observado para os outros grupos. Análises histológicas do fígado dos animais não apresentaram a formação de esteatose microvesicular para NCQ em comparação com a formação de esteatoses em todos os outros grupos, incluindo o grupo controle. Ao final, os resultados indicaram que NCQ possa ser uma formulação em potencial, necessitando ser investigada pelo aumento da penetração cerebral de AV e efeito hepatoprotetor observados. / Epilepsy is usually a combination of genetic pre-disposition and a disease or a brain damage. About 1 in 50 to 100 people has this genetic predisposition to seizures. One of the world’s most prescribed drugs to treat epileptic seizures is valproic acid (VA), which is the first choice drug to treat epilepsy in childhood due to its broad spectrum of action, although its well known side effects such as pancreatitis, hepatotoxicity can be fatal. Nanoparticulated systems such as nanocapsules, obtained from biodegradable polymers like polyethylene glycol and natural macromolecules like chitosan, who gives the system hidrophilicity and bioadhesivity, have been used to increase brain penetration and reduce drug doses. In this context, the present work aimed to develop and physicochemically characterize poly(ε-caprolactone) nanocapsules loaded with VA and coated with chitosan (NCQ) and/or polyethylene glycol (PEG) 6000 (NCP and NCQP), and to investigate their plasma pharmacokinetics, VA blood-brain barrier penetration (BBB) by microdialysis and hepatotoxicity in Wistar rats. Nanocapsules coated with chitosan were obtained by nanoprecipitation of preformed polymer followed by coating with 1% chitosan solution added prior to final adjustments at a volume of 5 mL. For NCP preparation, similar methodology was used adding 0.7% PEG 6000 in the aqueous phase. For NCQP preparation, the nanocapsules prepared with PEG 6000 (0.35% w/v) was further coated with chitosan 1% in solution adding 2.5 mL prior to the final adjustments. The formulations were physicochemical characterized by particle size, zeta potential, pH, incorporation efficiency. The particles were visualized by MET and the stability investigated by backscattering (Turbiscan Lab®). The formulations (VA 5 mg/mL) presented small particle sizes (144.2 ± 2.0 nm, 153.2 ± 1.8 nm, and 231.3 ± 15.6 nm, for NCQ, NCP and NCQP, respectively), with low polidispersion index, high incorporation efficiency (95 to 98 %) and acid pH. The zeta potential was positive for NCQ (+8.7 ± 0.4 mV) and negative for NCP (- 6.6 ± 0.8 mV) and NCQP (- 2.8 ± 1.3 mV). The photomicrography of all formulations showed spherically shaped particles. The formulations showed good stability during 24 hours investigation at 40 ºC. Plasma concentrations were investigated in Wisar rats after 15 mg/kg i.v. dosing of all formulations and sodium valproate solution (control group). The pharmacokinetic compartmental analysis showed a very rapid distribution of VA when incorporated in NCQ in comparison to the other formulations and the AUC0-∞ about two times lower in comparison to NCP, NCQP and the drug alone (3874 ± 1775; 8280 ±2136; 7849 ± 1021 and 7978 ± 3622 μg/mL/min, respectively). VA clearance was significantly increased after NCQ dosing (0.284 ± 0.156 L/h/kg) (α = 0.05 %). Drug penetration through BBB was performed in awaken Wistar rats by brain microdialysis at the frontal cortex using CMA/12 probes (3 mm). The microdialysis experiments showed a five times increase in VA brain penetration factor after NCQ administration in comparison to drug alone (0.110 and 0.021, respectively), demonstrating the viability of chitosan as coating polymer to aim the BBB. NCP showed only a 1.7 times increase in brain penetration factor and NCQP did not showed any difference in comparison to drug alone. The investigation of drug hepatotoxicity was conducted after 5 days i.v. dosing of VA 30 mg/kg q12h as solution or nanocapsules (NCQ or NCP). A saline control group was also investigated. Serum levels of asparte aminotransferase, alanine aminotransferase, gamma-glutamyltransferase, alkaline phosfatase, creatinin and urea were determined. The results showed the maintenance of normal levels of hepatic enzymes such as alanine aminotransferase and alkaline phosfatase for NCQ (54.2 ± 11.2 IU/mL and 149 ± 26 IU/mL) showing a hepatoprotective effect not observed in the other groups investigated. Histological analysis of animals livers showed no microvesicular steatosis formation when NCQ was administered in comparison with the formation of steatosis in all other groups including control. Overall the results indicate that NCQ is a potential formulation to be investigated for the treatment of epilepsy due to its increase in VA brain penetration and hepatoprotective effect observed.